MoonLake Immunotherapeut... Stock Quote MLTX - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

40.94

Bid

40.87

Ask

41.00

Volume

22,235

40.9165 Day's Range 41.76

20.3501 52 Week Range 64.98

Market Cap

2.641B

Previous Close

41.77

Open

41.25

Last Trade

40.94

Last Trade Time

10:45:14

Financial Volume

$ 916,093

VWAP

41.2005

Average Volume (3m)

483,757

Shares Outstanding

63,886,757

Dividend Yield

PE Ratio

-59.91

Earnings Per Share (EPS)

-0.69

Revenue

Net Profit

-44.08M

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

Sector

Blank Checks

Industry

Pharmaceutical Preparations

Website

moonlaketx.com

Headquarters

Grand Cayman, Cym

Founded

2020

MoonLake Immunotherapeutics is listed in the Blank Checks sector of the NASDAQ with ticker MLTX. The last closing price for MoonLake Immunotherapeut... was $41.77. Over the last year, MoonLake Immunotherapeut... shares have traded in a share price range of $ 20.3501 to $ 64.98.

MoonLake Immunotherapeut... currently has 63,886,757 shares outstanding. The market capitalization of MoonLake Immunotherapeut... is $2.64 billion. MoonLake Immunotherapeut... has a price to earnings ratio (PE ratio) of -59.91.

MoonLake Immunotherapeutics inks three-year technology partnership with Komodo Health to advance research on inflammatory skin and joint conditions

MoonLake Immunotherapeutics inks three-year technology partnership with Komodo Health to advance research on inflammatory skin and joint conditions MoonLake to tap into Komodo’s technology and...

Form 8-K - Current report

MoonLake announces significant improvements with Nanobody® sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day

MoonLake announces significant improvements with Nanobody® sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day Positive 24-week data...

MoonLake Immunotherapeutics to present MIRA trial data of Nanobody® sonelokimab in hidradenitis suppurativa as a late breaker at the AAD Annual Meeting 2024

MoonLake Immunotherapeutics to present MIRA trial data of Nanobody® sonelokimab in hidradenitis suppurativa as a late breaker at the AAD Annual Meeting 2024 ZUG, Switzerland, March 4, 2024 –...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.54	-1.30183220829	41.48	43.6	40.82	318451	42.60210374	CS
4	-6.66	-13.9915966387	47.6	48.38	40.68	357344	44.43802213	CS
12	-17.97	-30.5041588864	58.91	64.98	40.68	483757	49.76852409	CS
26	-9.12	-18.2181382341	50.06	64.98	35.11	567523	49.11529574	CS
52	18.51	82.5234061525	22.43	64.98	20.3501	600729	48.55746754	CS
156	28.57	230.96200485	12.37	64.98	4.25	356859	41.96217078	CS
260	28.57	230.96200485	12.37	64.98	4.25	356859	41.96217078	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AKLIAkili Inc	$ 0.4133 (75.95%)	44.53M
AGBAAGBA Group Holding Ltd	$ 3.6904 (57.04%)	67.24M
GMMGlobal Mofy Metaverse Ltd	$ 1.415 (52.10%)	52.58M
WGSGeneDx Holdings Corporation	$ 15.86 (44.18%)	1.98M
CYCCCyclacel Pharmaceuticals Inc	$ 1.96 (44.12%)	16.38M
LICNLichen China Limited	$ 1.4988 (-26.17%)	860.67k
NRXPNRX Pharmaceuticals Inc	$ 2.7343 (-22.98%)	585.15k
CETXCemtrex Inc	$ 1.39 (-21.91%)	123.62k
LUCYInnovative Eyewear Inc	$ 0.1957 (-18.76%)	300.05k
CSLRComplete Solaria Inc	$ 0.5947 (-18.56%)	1.71M
EGOXNext e GO NV	$ 0.0345 (25.00%)	71.87M
AGBAAGBA Group Holding Ltd	$ 3.70 (57.45%)	67.24M
GWAVGreenwave Technology Solutions Inc	$ 0.0685 (5.38%)	54.53M
JAGXJaguar Health Inc	$ 0.2448 (17.69%)	54.33M
GMMGlobal Mofy Metaverse Ltd	$ 1.415 (52.10%)	52.58M